BioSpace News Archive

Business

Advanced Bifurcation Systems Appoints Industry Veteran Thomas O’Neill to Board of Directors

Mr. O’Neill is an industry veteran who brings more than 30 years of Board and executive-level experience in the financial markets and medical devices to ABS.

January 25, 2018
·
3 min read
Biotech Bay

Five Prime Announces Pricing of Upsized Public Offering of Common Stock

The offering is expected to close on January 29, 2018, subject to customary closing conditions.

January 25, 2018
·
4 min read
Business

BGI Increases Long-Read Sequencing Capacity With Purchase of 10 PacBio Sequel Systems

This will significantly expand the capacity for Single Molecule, Real-Time Sequencing for BGI’s global sequencing service business, which currently operates two Sequel Systems and a PacBio RS II Sequencing System.

January 25, 2018
·
4 min read
Business

Vascular Insights Announces New CEO

The company’s Board of Directors has appointed James P. Ott as President and CEO.

January 25, 2018
·
1 min read
Policy

Alnylam Announces EMA Acceptance of MAA for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis

The filing of the MAA was previously announced on December 18, 2017.

January 25, 2018
·
8 min read
Business

Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018

The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

January 25, 2018
·
1 min read
Pharm Country

Senseonics Announces Proposed Convertible Senior Subordinated Notes Offering

Senseonics today announced a proposed underwritten offering, subject to market and other conditions, of convertible senior subordinated notes due 2023 (the Notes).

January 25, 2018
·
4 min read
Policy

BIOLASE Rejects Frivolous, Abusive Patent Litigation

Biolase responded to the latest attempt by CAO Group to use patent litigation to try to improve its competitive position in the marketplace.

January 25, 2018
·
5 min read
Business

ESSA Announces Management Team Change

ESSA Pharma announced today that Frank Perabo, M.D., Ph.D., will depart ESSA as the Company’s Chief Medical Officer to pursue other opportunities, effective January 31, 2018.

January 25, 2018
·
5 min read
Business

Elanco Announces Global Agreement with Ab E Discovery for New Technology

Developed at the University of Wisconsin-Madison by Drs. Mark Cook and Jordan Sand, this unique innovation targets anti-nutritional challenges found in an animal’s gut.

January 25, 2018
·
3 min read